Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) and their anticoagulation and antiplatelet activity studied using the Born method and clotting
tests. The synthesized amides
activity of some new nitrogen-containing heterocyclic derivatives relating to hemostasis system in
vitroYe, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) targeting JNK. In the present study, we have
tested the hypothesis that C66 could prevent obesity
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) in DCM and to
test the therapeutic effects of MD2 inhibitor C30 on DCM. Streptozotocin (STZ) was used
-crown-6 ether in toluene. In
vitro anticoagulant and antiplatelet activity of the adduct was studied
Pashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) -positive and gram-negative bacteria, fungi, hemolytic activity, cell toxicity (MTT-
test) and in
vitro anticoagulant
Luo, W.,
Chen, X.,
Ye, L.,
Chen, X.,
Jia, W.,
Zhao, Y.,
Samorodov, A.V.,
Zhang, Y.,
Hu, X.,
Zhuang, F.,
Qian, J.,
Zheng, C.,
Liang, G.,
Wang, Y. (2021) DN. NRK-52E, a tubular epithelial cell line, was used for in
vitro analysis. TRAF6 was knockdown
-substituted thietane-1,1-dioxide derivative (N-199/1) exhibiting antidepressant properties, in several
tests is performed according to the “guidance on preclinical
research of new pharmacological substances” in
vitroURAKOV, A.L.,
MUSTAFIN, I.G.,
NABIULLINA, R.M.,
BASHIROVA, L.I.,
MOCHALOV, K.S.,
SAMORODOV, A.V.,
KHALIULLIN, F.A.,
LIPATOV, D.O.,
KORUNAS, V.I.,
KHALIMOV, A.R. (2020) activated TEG, in
vitro hemostatic system hyperactivity modeling was carried out with the blood of healthy